Definitive irradiation in the treatment of Hodgkin's disease: Analysis of outcome, prognostic factors, and long term complications

Cancer

Volumn 79, Issue 1, 1997, Pages 145-151

  Sears, Judith D ^a   Greven, Kathryn M ^a   Ferree, Carolyn R ^a   D'Agostino Jr , Ralph B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

complications; dose response; Hodgkin's disease; radiotherapy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SECOND CANCER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 0031032391     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970101)79:1<145::AID-CNCR21>3.0.CO;2-3     Document Type: Article

References (22)

1. Hodgkin T. On some morbid appearances of the absorbent glands and spleen. Medico-Chirurgical Transactions 1832; 17:68-114.
2. Hoppe RT, Coleman CN, Cox RS, Rosenberg SA, Kaplan HS. The management of stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience. Blood 1982;59:455-65.
3. Mauch P, Tarbell N, Weinstein H, Silver B, Goffman T, Osteen R, et al. Stage IA and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and para-aortic irradiation. J Clin Oncol 1988;6:1576-83.
4. Farah R, Ultman J, Griem M, Golomb H, Kalokhe V, Desser R, et al. Extended mantle radiotherapy for pathologic Stage I and II Hodgkin's disease. J Clin Oncol 1988;6:1047-52.
5. Hartsell W, Sarin P, Recine D. Long-term results of curative irradiation in pathologically staged IA and IIA Hodgkin's disease. Radiology 1993;186:565-8.
6. Schewe K, Reavis J, Kun L, Cox J. Total dose, fraction size, and tumor volume in the local control of Hodgkin's disease. Int Radiat Oncol Biol Phys 1988;15:25-8.
7. Hanks G, Kinzie J, White R, Herring D, Kramer S. Patterns of Care Outcome Studies: results of the national practice in Hodgkin's disease. Cancer 1983;51:569-73.
8. Thar T, Million R, Hausner R, McKetty M. Hodgkin's disease Stages I and II: relationship of recurrence to size of disease, radiation dose, and number of sites involved. Cancer 1979;43:1101-5.
9. Fletcher GH, Shukovsky LS. The interplay of radiocurability and tolerance in the irradiation of human cancers. J Radiol Electrol 1975;56:383-400.
10. Carbone PD, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971;31:1860-1.
11. Kaplan ES, Meier P. Nonparametric estimation from incomplete observation. Am Stat Assoc J 1958;53:457-80.
12. Tubiana M, Henry-Amar M, van der Werf-Messing B, Henry J, Abbatucci J, Burger M, et al. A multivariate analysis of prognostic factors in early stage Hodgkin's disease. Int J Radiat Oncol Biol Phys 1985;11:23-30.
13. Lee CKK, Aeppli DM, Bloomfield CD, Levitt S. Hodgkin's disease: a reassessment of prognostic factors following modification of radiotherapy. Int J Radiat Oncol Biol Phys 1987;13:983-91.
14. Cox JD, Stoffel TJ. Clinical versus pathologic Stage I and II Hodgkin's disease. Oncology 1980;37:325-8.
15. Leslie NT, Mauch PM, Hellman S. Stage IA to IIB Supradiaphragmatic Hodgkin's disease: long-term survival and relapse frequency. Cancer 1985;55:2072-8.
16. Mendenhall NP, Taylor BW, Marcus RB, Million RR. The impact of pelvic recurrence and electric pelvic irradiation on survival and treatment morbidity in early stage Hodgkin's disease. Int J Radiat Oncol Biol Phys 1991;21:1157-65.
17. Tate DJ, Hoppe RT. Pelvic relapse following subtotal lymphoid irradiation in early stage Hodgkin's disease: an analysis of risk, management, and outcome. Int J Radiat Oncol Biol Phys 1995;32:1239-44.
18. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
19. Coia LR, Hanks GE. Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin's disease and seminoma. Int J Radiat Oncol Biol Phys 1988;15:29-35.
20. Rodriguez MA, Fuller LM, Zimmerman SO, Allen PK, Brown BW, Monsell MF, et al. Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann Oncol 1993;4:125-31.
21. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988;318:76-81.
22. Robinson BA, Colls BM, Fitzharris BM, Atkinson CM. Second malignant neoplasms in patients with Hodgkin's disease. Aust N Z J Med 1994;24:368-73.